HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Harada Selected Research

K Harada Research Topics

Disease

26Neoplasms (Cancer)
03/2022 - 01/2000
10Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
08/2009 - 01/2000
7Carcinoma (Carcinomatosis)
01/2008 - 03/2001
5Esophageal Neoplasms (Esophageal Cancer)
06/2018 - 09/2000
5Cholangitis
08/2013 - 08/2000
5Cholangiocarcinoma
09/2007 - 01/2000
4Inflammation (Inflammations)
04/2018 - 08/2009
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2016 - 05/2001
4Hypoxia (Hypoxemia)
08/2015 - 02/2000
4Necrosis
08/2013 - 02/2001
3Lymphoma (Lymphomas)
07/2021 - 03/2001
3Alopecia Areata
01/2020 - 12/2001
3Melanoma (Melanoma, Malignant)
05/2016 - 03/2011
3Infections
08/2013 - 11/2000
3Ulcerative Colitis
02/2009 - 07/2005
3Insulin Resistance
03/2006 - 03/2001
3Mucocutaneous Lymph Node Syndrome (Kawasaki Disease)
11/2002 - 10/2000
3Atherosclerosis
10/2001 - 07/2000
3Hepatocellular Carcinoma (Hepatoma)
04/2001 - 07/2000
3Granuloma
03/2001 - 08/2000
3Liver Diseases (Liver Disease)
02/2001 - 01/2001
3Glioma (Gliomas)
12/2000 - 03/2000
3Hepatitis
10/2000 - 01/2000
2Bites and Stings (Sting)
09/2021 - 08/2021
2Anaphylaxis (Anaphylactic Shock)
09/2021 - 08/2021
2Stomach Neoplasms (Stomach Cancer)
01/2021 - 10/2000
2Weight Loss (Weight Reduction)
03/2018 - 10/2000
2Renal Cell Carcinoma (Grawitz Tumor)
09/2014 - 10/2013
2Schizophrenia (Dementia Praecox)
04/2013 - 06/2010
2Autoimmune Diseases (Autoimmune Disease)
08/2009 - 06/2001
2Adenocarcinoma
09/2007 - 09/2000
2Hypersensitivity (Allergy)
04/2007 - 04/2002
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
05/2006 - 01/2005
2Brain Ischemia (Cerebral Ischemia)
05/2006 - 01/2005
2Infarction (Infarctions)
01/2005 - 01/2001
2Cardiomyopathies (Cardiomyopathy)
08/2004 - 12/2000
2Ventricular Heart Septal Defects (Ventricular Septal Defect)
11/2002 - 05/2001
2Familial Hypertrophic Cardiomyopathy (Cardiomyopathy, Familial Hypertrophic)
12/2001 - 02/2000
2Lung Neoplasms (Lung Cancer)
11/2001 - 09/2000
2Disease Progression
09/2001 - 05/2000
2Candidiasis (Moniliasis)
07/2001 - 02/2001
2Glioblastoma (Glioblastoma Multiforme)
06/2001 - 10/2000
2Fibrosis (Cirrhosis)
02/2001 - 10/2000
2Brain Neoplasms (Brain Tumor)
12/2000 - 03/2000
2Ischemia
11/2000 - 02/2000
2Neoplasm Metastasis (Metastasis)
10/2000 - 01/2000

Drug/Important Bio-Agent (IBA)

9Proteins (Proteins, Gene)FDA Link
03/2022 - 01/2000
9AntigensIBA
09/2021 - 02/2000
6DNA (Deoxyribonucleic Acid)IBA
06/2001 - 09/2000
5AntibodiesIBA
03/2012 - 10/2000
4Biological ProductsIBA
09/2007 - 02/2000
4Telomerase (Telomerase Reverse Transcriptase)IBA
05/2006 - 03/2000
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2001 - 02/2000
4Messenger RNA (mRNA)IBA
04/2001 - 08/2000
3Biomarkers (Surrogate Marker)IBA
03/2022 - 12/2001
3Pharmaceutical PreparationsIBA
01/2021 - 01/2001
3Insulin (Novolin)FDA Link
06/2001 - 02/2001
3Fas Ligand Protein (Fas Ligand)IBA
04/2001 - 04/2000
3ApolipoproteinsIBA
03/2001 - 07/2000
316S Ribosomal RNAIBA
03/2001 - 07/2000
2LeptinIBA
04/2018 - 10/2001
2CytokinesIBA
08/2013 - 07/2005
2InterleukinsIBA
08/2013 - 08/2009
2InterferonsIBA
08/2013 - 11/2006
2AutoantibodiesIBA
06/2012 - 06/2001
2Cisplatin (Platino)FDA LinkGeneric
01/2008 - 04/2003
2RNA (Ribonucleic Acid)IBA
01/2008 - 08/2000
2CholesterolIBA
03/2006 - 10/2001
2NF-kappa B (NF-kB)IBA
07/2005 - 04/2003
2LipopolysaccharidesIBA
07/2005 - 02/2000
2TroponinIBA
08/2004 - 02/2000
2Peptides (Polypeptides)IBA
04/2002 - 09/2000
2AutoantigensIBA
04/2002 - 01/2001
2Troponin T (Troponin T1)IBA
01/2002 - 02/2000
2retinoic acid receptor betaIBA
12/2001 - 11/2001
2MucinsIBA
12/2001 - 06/2001
2LDL Receptors (LDL Receptor)IBA
10/2001 - 07/2000
2Lipoproteins (Lipoprotein)IBA
10/2001 - 08/2000
2Bacterial DNAIBA
08/2001 - 07/2000
2LipidsIBA
05/2001 - 08/2000
2ParaffinIBA
05/2001 - 05/2001
2Oxygen (Dioxygen)IBA
05/2001 - 11/2000
2Hemoglobins (Hemoglobin)IBA
02/2001 - 10/2000
2SteroidsIBA
01/2001 - 10/2000
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2001 - 10/2000
2Free RadicalsIBA
11/2000 - 01/2000
2Immunoglobulin G (IgG)IBA
10/2000 - 09/2000
2IntegrinsIBA
08/2000 - 01/2000
2Fibronectins (Fibronectin)IBA
08/2000 - 01/2000
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2000 - 01/2000
1Immune Checkpoint InhibitorsIBA
03/2022
1pembrolizumabIBA
03/2022
1NivolumabIBA
01/2021
1Protein Isoforms (Isoforms)IBA
01/2021
1Irinotecan (Camptosar)FDA LinkGeneric
01/2021

Therapy/Procedure

13Therapeutics
08/2016 - 07/2000
3Esophagectomy
06/2018 - 05/2016
3Radiotherapy
01/2008 - 12/2001
2Drug Therapy (Chemotherapy)
07/2021 - 05/2001
2Immunotherapy
09/2000 - 02/2000